Slingshot Insights | Med Day Pharmaceuticals Overview

MEDDAY PHARMACEUTICALS Overview

Upcoming Projects (MEDDAY PHARMACEUTICALS)

Don’t see a project related to the company you care about? Create your own!

Executed Projects (MEDDAY PHARMACEUTICALS)

Don’t see a project related to the company you care about? Create your own!

Expired Projects (MEDDAY PHARMACEUTICALS)

Evaluating the Multiple Sclerosis Market After AbbVie (ABBV) and Biogen (BIIB) Receive CHMP Support for EU Approval of Zinbryta
Tickers: ABBV, BIIB, TEVA, NVS, SNY, MedDay Pharmaceuticals, RHHBY
Execute By: May 23, 2016
Reviewing MedDay Pharmaceuticals's Phase IIb/3 Data For MD1003 in Not-Active Progressive MS, and How it Affects the Market Potential of Roche's (RHHBY) Breakthrough Therapy Ocrelizumab for Primary Progressive Multiple Sclerosis
Tickers: RHHBY, MedDay Pharmaceuticals
Execute By: May 11, 2016

Upcoming & Overdue Catalysts (MEDDAY PHARMACEUTICALS)

Don’t see a catalyst related to the company you care about? Create your own!

Strategic Initiatives (MEDDAY PHARMACEUTICALS)

Don’t see a strategic initiative related to the company you care about? Create your own!